Publication:
Social Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study

dc.contributor.authorSALMAN, ANDAÇ
dc.contributor.authorTOPÇUOĞLU, VOLKAN
dc.contributor.authorsSalman, Andac; Kurt, Emel; Topcuoglu, Volkan; Demircay, Zeynep
dc.date.accessioned2022-03-12T20:27:52Z
dc.date.accessioned2026-01-10T19:02:25Z
dc.date.available2022-03-12T20:27:52Z
dc.date.issued2016
dc.description.abstractVitiligo and acne vulgaris, commonly affecting the face, have significant psychological effects and impair the quality of life of the affected individuals. Because of their negative effect on physical appearance, these conditions may act as a potential barrier to social relationships and cause social anxiety. The objective of the study was to investigate the social anxiety, quality of life, anxiety, and depression levels of acne and vitiligo patients with facial involvement and compare these levels with healthy controls. Thirty-seven vitiligo and 37 acne patients, aged older than 18 years, with facial involvement and 74 age- and sex-matched healthy control subjects were included in the study. The patients and healthy controls were asked to complete the Liebowitz Social Anxiety Scale, the Hospital Anxiety and Depression Scale, and the Dermatology Life Quality Index. Disease severity was evaluated both objectively by the physician and subjectively by the patients using a visual analog scale. Social anxiety, depression, and anxiety levels of vitiligo and acne patients were significantly higher than healthy controls (p < 0.05). Quality of life was impaired in both patient groups (Dermatology Life Quality Index scores for vitiligo: 5.6 +/- A 5.1; acne: 6.4 +/- A 6.2). There was no correlation between psychiatric scale scores and disease severity. Quality of life was negatively correlated with social anxiety and depression levels in both patient groups in our study. Vitiligo and acne patients had higher levels of social anxiety, anxiety, and depression compared with healthy control subjects. Considering that increased psychosocial morbidity was regardless of age, sex, and disease severity and was correlated with quality of life impairment, evaluation of the psychosocial morbidity, in particular social anxiety, may be valuable in all vitiligo and acne patients.
dc.identifier.doi10.1007/s40257-016-0172-x
dc.identifier.eissn1179-1888
dc.identifier.issn1175-0561
dc.identifier.pubmed26818062
dc.identifier.urihttps://hdl.handle.net/11424/233799
dc.identifier.wosWOS:000376102000009
dc.language.isoeng
dc.publisherADIS INT LTD
dc.relation.ispartofAMERICAN JOURNAL OF CLINICAL DERMATOLOGY
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectPSYCHIATRIC MORBIDITY
dc.subjectDERMATOLOGY PATIENTS
dc.subjectCLINICAL-VARIABLES
dc.subjectATOPIC-DERMATITIS
dc.subjectTURKISH VERSION
dc.subjectDEPRESSION
dc.subjectPHOBIA
dc.subjectVULGARIS
dc.subjectINDEX
dc.subjectSEVERITY
dc.titleSocial Anxiety and Quality of Life in Vitiligo and Acne Patients with Facial Involvement: A Cross-Sectional Controlled Study
dc.typearticle
dspace.entity.typePublication
oaire.citation.endPage311
oaire.citation.issue3
oaire.citation.startPage305
oaire.citation.titleAMERICAN JOURNAL OF CLINICAL DERMATOLOGY
oaire.citation.volume17

Files